|Bid||0.0800 x N/A|
|Ask||0.0850 x N/A|
|Day's Range||0.0750 - 0.0850|
|52 Week Range||0.0350 - 0.2300|
|Beta (5Y Monthly)||4.24|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 23, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CALGARY, AB, March 23, 2021 /CNW/ - Nauticol and Enhance have entered into an agreement to work collaboratively for the capture and sequestration of up to one million tonnes of CO2 each year from Nauticol's planned Blue Methanol facility to be built near Grande Prairie, Alberta.Nauticol is building a world scale methanol production and distribution business to supply the unmet and rapidly growing global demand for low carbon methanol.
TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), developer of a fully-integrated blockchain platform for the legal cannabis, food, and pharmaceutical industries, today announced that it has signed a letter of intent (LOI) with Georgia-based PharmaCentra LLC – through its subsidiary CannabisBPO -- to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry.
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace Technologies, Inc. (CSE: TTT) ("TruTrace"), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, to approach the cannabis industry with an integrated solution comprised of Applied DNA’s CertainT® platform and TruTrace’s StrainSecure™ platform to deliver a complete cannabis product validation and authentication platform differentiated in the marketplace by linking together the power of proprietary SaaS platforms, blockchain and molecular tagging technology to create a secure ecosystem which provides end-to-end traceability and full transparency.